Sign In
Get Clay Free →

Suggestions

    Randall Carpenter

    Allos Pharma

    Randall Carpenter is an accomplished biotechnology executive with a rich background spanning over 35 years in leadership roles across academics, medicine, research, and therapeutic development. His primary focus involves translating scientific breakthroughs into innovative treatments for autism, Fragile X Syndrome, Rett Syndrome, and intellectual disability. Prior to his venture into the industry, Randall Carpenter's academic pursuits emphasized translational medicine.

    Having undergone extensive education and training, Randall Carpenter completed his Internship at the United States Public Health Service Hospital in San Francisco, his Research Fellowship at the University of California, San Francisco, and pursued studies in Engineering/Microbiology and MD in Medicine at the University of Michigan. Furthermore, he concluded his Residency in Anesthesiology at the Virginia Mason Medical Center.

    Throughout his career, Randall Carpenter has been associated with several notable organizations where he held pivotal roles. He co-founded Allos Pharma, served as the Chief Medical Officer at the Rett Syndrome Research Trust, worked as a Research Affiliate at the prestigious Massachusetts Institute of Technology (MIT), held the position of Chief Scientific Officer at the Rett Syndrome Research Trust, served as the Executive Vice President of Clinical Development at Quadrant Biosciences Inc, acted as the Co-Founder, President, CEO, and Director at Seaside Therapeutics, and assumed multiple roles at Sention including CEO, CMO, President, and Director. Additionally, he contributed as an Adjunct Associate Professor of Anesthesiology at Duke University Medical Center.

    Randall Carpenter
    Add to my network

    Location

    United States